Fig. 3From: Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populationsAssociations between stimulant use and initiation of buprenorphine or extended-release naltrexone. Results from randomized controlled trials are generalized to target populations with opioid misuse. MOUD medication for opioid use disorder, CTN RCT National Drug Abuse Treatment Clinical Trials Network, NSDUH National Survey on Drug Use and Health, TEDS Treatment Episodes Dataset, ROI Rural Opioids Initiative, XR-NTX extended-release naltrexone, Bup buprenorphine, aHR adjusted hazard ratioBack to article page